Benzinga - U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session.
- Esperion Therapeutics, Inc. (NASDAQ: ESPR) dropped 50.3% to $1.98 in pre-market. In 8-K Filing Wednesday, Esperion reported partner Daiichi Sankyo Europe said Esperion is not entitled to receive milestone payments based on CLEAR outcomes data in trial of Bempedoic acid to treat cholesterol.
- Virgin Orbit Holdings, Inc. (NASDAQ: VORB) shares dipped 43.9% to $0.5670 in pre-market trading after CNBC said, ‘Virgin Orbit pauses operations for a week, furloughs nearly entire staff as it seeks funding.’
- LivePerson, Inc. (NASDAQ: LPSN) shares tumbled 38.4% to $6.02 in pre-market trading after the company posted downbeat Q4 sales and issued weak revenue forecast.
Don’t forget to check out our premarket coverage here
- Amyris, Inc. (NASDAQ: AMRS) declined 17.7% to $0.98 in pre-market trading after posting a loss for the fourth quarter.
- Proterra Inc. (NASDAQ: PTRA) dipped 16.3% to $2.10 in pre-market trading after the company posted downbeat Q4 results and issued weak FY23 revenue forecast.
- Burford Capital Limited (NYSE: BUR) shares declined 14.5% to $6.54 in pre-market trading after the company issued an update on its 2022 business activity.
- First Republic Bank (NYSE: FRC) shares dropped 6.4% to $29.16 in pre-market trading. Bloomberg reported that First Republic Bank is said to weigh options including a sale, citing people with knowledge of the matter.
- Baidu, Inc. (NASDAQ: BIDU) fell 5.2% to $126.19 in pre-market trading. Baidu recently launched AI Chat app WiseAI overseas following release of its AI virtual chat community app Xiaokan Planet in China.
- Tremor International Ltd (NASDAQ: TRMR) shares dropped 4.8% to $5.38 in pre-market trading.
- AMC Entertainment Holdings, Inc. (NYSE: APE) fell 4.2% to $1.36 in pre-market trading.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Now Read This: S&P 500 Settles Lower Following Economic Reports, Market Volatility Increases
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.